23andMe

United States
Clarkdale, Arizona, United States, 94086

Company profile

23andMe company profile

23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits. It provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. A startup co-founded by Linda Avey and Anne Wojcicki, the wife of Google co-founder Sergey Brin, 23andMe has plans to make the human genome searchable. Brin, along with Google, gave 23andMe $3.9 million as part of a series A in May of 2007. The company was named after the number of chromosome pairs in humans. They aim to help people understand what their genes mean by indexing them and highlighting significant findings. 23andMe allows its clients/users to study their ancestry, genealogy, and inherited traits. The company also markets to researchers and scientists, for whom they provide neatly categorized and easily searchable data. One reason the Google investment in 23andMe made sense was that this company could enable the search giant to index another facet of the world's information. With the biotech and health care industries growing rapidly, 23andMe could help Google get and maintain a market hold in these already multi-billion-dollar areas.

Business identity

Contact email
[email protected]
Phone number
650-938-6305
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$10M-$100M
Founded
2006-04-01

Headquarters

Postal code
94086
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
14
Total equity funding
$1.1B
Last funding
Post IPO Equity / $250M / 2021-06-17
Last equity funding
Post IPO Equity / $250M
Investors
36
Lead investors
7
Founders
3
Articles
2,571
Exited on
2025-03-31

Founders and investors

Founders

Anne WojcickiLinda AveyPaul Cusenza

Lead investors

FidelityGlaxoSmithKlineGoogleJohnson & Johnson Development CorporationNational Institutes of HealthNewView CapitalSequoia Capital

Investors

Altimeter CapitalFidelityForesite CapitalNew Enterprise AssociatesSequoia Capital